Today the National Academies of Sciences (NAS) and the American Association for the Advancement of Science (AAAS), released their survey of Attitudes and Actions on Dual Use Research in the Life Sciences. The survey was sent to AAAS members whose primary area of research was in the life sciences in order to assess their awareness of and attitudes toward “dual-use” research-studies undertaken for beneficial purposes that could also have harmful applications. The survey also explored actions the scientists might support to reduce the risk of misuse of research, as well as steps that scientists may already be taking in response to these concerns.
David Franz of the Midwest Research Institute and Ronald M. Atlas of the University of Louisville, two of the members of the committee which reviewed the survey results and wrote the final report presented the main findings. David Franz began by defining dual-use research and its importance within the life sciences community and Ronald Atlas discussed the primary findings of the survey. Atlas noted that a low response rate and uncertainty about whether the sample is representative of the broader life sciences community limits the ability to draw definitive conclusions. Nonetheless, the survey results are useful and informative and Atlas went on to explain that the results indicate that some respondents have already been so concerned about dual-use issues that they have altered their research or experiments. Even in the absence of guidelines or government restrictions some scientists have already taken action to try to avert misuse of biomedical research.
Copies of A Survey of Attitudes and Actions on Dual Use Research in the Life Sciences: A Collaborative Effort of the National Research Council and the American Association for the Advancement of Science are available from the National Academies Press.
Today’s presentation can be heard via podcast from the National Academies website.
The post NAS-AAAS Dual-Use Research Survey Results Released appears on the FAS Strategic Security Blog.